関連する実験動画
Updated: Feb 19, 2026

05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
264
世界におけるサポートケア:MASCCの展望に関する国際的見解
Fatma Ben Abid1, Mounir Bachouchi1, Corina Van Den Hurk2
1Department of Supportive Care, Oncology Clinic 16 novembre, Rabat, Morocco.
Current opinion in oncology
|February 18, 2026
まとめ
サポートケアは,がん患者にとって不可欠です.
科学分野:
- 腫瘍学 腫瘍学
- サポートケアによる介護です.
- グローバル・ヘルス・エクイティ・エクイティ
背景:
- サポートケアは,がん患者の生存と生活の質にとって根本的なものです.
- 世界的ながん生存率の向上のために,サポートケアを普遍的に統合することはますます緊急です.
- 持続的な不平等は,多様な保健システムにおけるサポートケアの実施を脅かしています.
研究 の 目的:
- 腫瘍学におけるサポートケアに関する現在の世界情勢を検証する.
- 支援介護の実施における持続的な不平等を特定し,分析する.
- MASCCのような組織の支援介護の進歩における役割を強調する.
主な方法:
- 支援介護の進化と現在の状態のレビュー.
- 高所得国,低所得国および中所得国間のサポートケアへのアクセスにおける格差の分析.
- 主要組織 (MASCCなど) の貢献と将来のビジョンの検討.
主要な成果:
- マルチナショナル・アソシエーション・オブ・サポーティング・ケア・イン・ガン (MASCC) は,研究,ガイドライン,専門的なトレーニングを通じて,この分野を大幅に進歩させました.
- 大きな格差が依然として存在し,高所得国が低所得国や中所得国よりもサポートケアを効果的に統合している.
- 必要な医薬品,訓練を受けたスタッフ,生存支援プログラムへのアクセスが限られているため,多くの地域で支援ケアが困難になっています.
結論:
- サポートケアは基本的な権利であり,質の高いがん治療と生存のための前提条件です.
- MASCCのイニシアチブは,サポートケア2030運動を含む,グローバルな公平性と普遍的なアクセスを目指しています.
- 持続的なイノベーション,包括性,およびグローバルなコミットメントは,世界中のサポートケアを前進させるために不可欠です.
関連する概念動画
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
International Nursing Organizations I
2.3K
International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
2.3K
Cancer Survival Analysis
787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
